upcoming glp-1 drugs New oral drug delivers up to 12% weight loss in 36 weeks GLP-1 Market Trends and Global

Phase 3 TRANSCEND-T2D-1 (March 19, 2026) showed 16.8% loss at 12 mg over 40 weeks in adults with type 2 diabetes

Milliman's experts have diverse actuarial, operational, and market experience from decades in the realm of government healthcare services

Some people find that appetite suppression decreases somewhat over time

Wegovy dosing schedule and what to expect Managing side effects and tips that work Pricing, delivery, and how to get started Evidence for Anti-Inflammatory Effects of GLP-1 Drugs Accumulating preclinical and clinical evidence suggests that GLP-1 receptor agonists may possess anti-inflammatory properties that extend beyond their metabolic effects

The most well-known GLP-1 medications include: Approved for Diabetes: O zempic (semaglutide) : Approved by the FDA for the treatment of type 2 diabetes